Circulating ANGPTL8 levels were significantly increased in AAA patients compared with control subjects (402.2 ± 24.51 vs 653.8 ± 20.54 pg/ml; Figure 1F), and the clinical characteristics are shown in Supplementary Table S1. This evidence concerns the gene ANGPTL8 and triple-A syndrome.